Legal analysis: Now the cost of nucleic acid detection has been fully included in the medical insurance reimbursement, that is to say, if the cost of nucleic acid detection during hospitalization can be fully reimbursed, if it is an outpatient service, the patient needs to pay at his own expense or in his personal account. In the aspect of nucleic acid detection, if it is really necessary to set up temporary projects to meet the needs of COVID-19 detection fees of public medical institutions, all localities are encouraged to set up projects by means of "separation of technology and consumption".

Legal basis: Article 30 of the Social Insurance Law of People's Republic of China (PRC), the following medical expenses are not included in the scope of payment of the basic medical insurance fund: (1) those that should be paid by the industrial injury insurance fund; (2) It shall be borne by a third party; (three) shall be borne by public health; (4) Go abroad for medical treatment. Medical expenses that should be borne by a third party according to law. If the third party is unable to pay or cannot determine the third party, the basic medical insurance fund will pay in advance. After the basic medical insurance fund pays in advance, it has the right to recover from the third party.